According to the report, JD health has six cornerstone investors, including Singapores sovereign wealth fund, government investment company of Singapore (gicpte), Hillhead capital and BlackRock, who have agreed to subscribe for up to $1.35 billion in shares, the report said.
Jingdong health will set the price on December 1 and officially list on December 8.
According to the data set after the hearing, JD health has been operating independently since February 2014, launched online consultation service in December 2017, officially registered and established the company in 2018, completed a round of $900 million financing in November 2019 and $900 million in round B financing in August 2020. As of June 30, 2020, more than 150 million users have used the platform of JD health to purchase medicine and health products or medical and health services Business.
From 2017 to 2019, the total income of Jingdong health was 5.6 billion yuan, 8.2 billion yuan and 10.8 billion yuan respectively, and in the first half of 2020, it was 10.8 billion yuan. Excluding the items of fair value change and non recurring profit and loss, the net profit of Jingdong health from 2017 to 2019 was 210 million yuan, 250 million yuan and 340 million yuan, and 370 million yuan in the first half of 2020.